257 related articles for article (PubMed ID: 35500538)
1. A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice.
Perera DJ; Hassan AS; Liu SS; Elahi SM; Gadoury C; Weeratna RD; Gilbert R; Ndao M
EBioMedicine; 2022 Jun; 80():104036. PubMed ID: 35500538
[TBL] [Abstract][Full Text] [Related]
2. Adjuvanted
Perera DJ; Hassan AS; Jia Y; Ricciardi A; McCluskie MJ; Weeratna RD; Ndao M
Front Immunol; 2020; 11():605288. PubMed ID: 33304354
[TBL] [Abstract][Full Text] [Related]
3. Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.
Molehin AJ; Sennoune SR; Zhang W; Rojo JU; Siddiqui AJ; Herrera KA; Johnson L; Sudduth J; May J; Siddiqui AA
Parasitol Res; 2017 Nov; 116(11):3175-3188. PubMed ID: 29026995
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.
Ricciardi A; Dalton JP; Ndao M
Vaccine; 2015 Jan; 33(2):346-53. PubMed ID: 25448114
[TBL] [Abstract][Full Text] [Related]
5. A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis.
Ricciardi A; Visitsunthorn K; Dalton JP; Ndao M
BMC Infect Dis; 2016 Mar; 16():112. PubMed ID: 26945988
[TBL] [Abstract][Full Text] [Related]
6. Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model.
Hassan AS; Zelt NH; Perera DJ; Ndao M; Ward BJ
PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007490. PubMed ID: 31790394
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic activity of a Salmonella-vectored Schistosoma mansoni vaccine in a mouse model of chronic infection.
Hassan AS; Perera DJ; Ward BJ; Ndao M
Vaccine; 2021 Sep; 39(39):5580-5588. PubMed ID: 34412919
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 vaccine-specific responses induced by Listeria vector vaccines are maintained in mice subsequently infected with a model helminth parasite, Schistosoma mansoni.
Shollenberger LM; Bui CT; Paterson Y; Nyhoff L; Harn DA
Vaccine; 2013 Nov; 31(48):5651-8. PubMed ID: 24120546
[TBL] [Abstract][Full Text] [Related]
9. Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity.
El Ridi R; Tallima H; Selim S; Donnelly S; Cotton S; Gonzales Santana B; Dalton JP
PLoS One; 2014; 9(1):e85401. PubMed ID: 24465551
[TBL] [Abstract][Full Text] [Related]
10. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
[TBL] [Abstract][Full Text] [Related]
11.
Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
Front Immunol; 2018; 9():1762. PubMed ID: 30105029
[TBL] [Abstract][Full Text] [Related]
12. A Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against
Alves CC; Araujo N; Bernardes WPOS; Mendes MM; Oliveira SC; Fonseca CT
Front Immunol; 2018; 9():2488. PubMed ID: 30450095
[TBL] [Abstract][Full Text] [Related]
13. A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection.
Da'Dara AA; Skelly PJ; Walker CM; Harn DA
Parasite Immunol; 2003; 25(8-9):429-37. PubMed ID: 14651590
[TBL] [Abstract][Full Text] [Related]
14. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.
Cardoso FC; Macedo GC; Gava E; Kitten GT; Mati VL; de Melo AL; Caliari MV; Almeida GT; Venancio TM; Verjovski-Almeida S; Oliveira SC
PLoS Negl Trop Dis; 2008 Oct; 2(10):e308. PubMed ID: 18827884
[TBL] [Abstract][Full Text] [Related]
15. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
El Ridi R; Tallima H
Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
[TBL] [Abstract][Full Text] [Related]
16. The Schistosoma mansoni cyclophilin A epitope 107-121 induces a protective immune response against schistosomiasis.
de Melo TT; Mendes MM; Alves CC; Carvalho GB; Fernandes VC; Pimenta DLF; de Moraes Mourão M; Gai F; Kalli M; Coelho A; de Azambuja Ribeiro RIM; Falcone FH; Pereira RADS; Fonseca CT
Mol Immunol; 2019 Jul; 111():172-181. PubMed ID: 31063938
[TBL] [Abstract][Full Text] [Related]
17. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.
Gonçalves de Assis NR; Batistoni de Morais S; Figueiredo BC; Ricci ND; de Almeida LA; da Silva Pinheiro C; Martins Vde P; Oliveira SC
PLoS One; 2015; 10(5):e0125075. PubMed ID: 25942636
[TBL] [Abstract][Full Text] [Related]
18. Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.
Zhang W; Ahmad G; Torben W; Noor Z; Le L; Damian RT; Wolf RF; White GL; Chavez-Suarez M; Podesta RB; Kennedy RC; Siddiqui AA
J Infect Dis; 2010 Apr; 201(7):1105-12. PubMed ID: 20187746
[TBL] [Abstract][Full Text] [Related]
19. Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.
Karmakar S; Zhang W; Ahmad G; Torben W; Alam MU; Le L; Damian RT; Wolf RF; White GL; Carey DW; Carter D; Reed SG; Siddiqui AA
Vaccine; 2014 Mar; 32(11):1296-303. PubMed ID: 24397898
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with enzymatically cleaved GPI-anchored proteins from Schistosoma mansoni induces protection against challenge infection.
Martins VP; Pinheiro CS; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Azevedo V; Castro-Borges W; Wilson RA; Oliveira SC
Clin Dev Immunol; 2012; 2012():962538. PubMed ID: 22927873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
